RxDoctor Payments Data

John Denker, MD

Adult Medicine · Gresham, ORNPI 1942201546

Payments from drug & device makers

$1,777in general payments, 2019–2025

Across 106 payments — averaging $16.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$250
  • Pfizer$230
  • Johnson & Johnson$191
  • Boehringer Ingelheim$139
  • Novartis$138
  • GSK$132
  • plus $698 from 12 others

What the payments were for

  • Food & beverage$1,74798%
  • Education$302%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few adult medicine providers in Oregonto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$30,293
Medicare patients
226
Services billed
365

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban262$111,277
MounjaroTirzepatide27$27,943
TrulicityDulaglutide17$19,843
OzempicSemaglutide18$18,364
XareltoRivaroxaban48$16,875
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$16,200
FarxigaDapagliflozin Propanediol32$14,116
TrintellixVortioxetine Hydrobromide15$11,013
NuedextaDextromethorphan Hbr/Quinidine11$9,578
JardianceEmpagliflozin20$7,430
MyrbetriqMirabegron17$6,089
Atorvastatin Calcium335$5,859
GemtesaVibegron20$5,608
EntrestoSacubitril/Valsartan16$5,558
Gabapentin163$3,991

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$230$111,277262 claims
Lilly USA, LLCMounjaro, Trulicity, Olanzapine$116$50,09468 claims
Johnson & JohnsonXarelto$191$16,87548 claims
GSKTrelegy Ellipta$132$16,20016 claims
AstraZenecaFarxiga$250$14,11632 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$40$11,01315 claims
Boehringer IngelheimJardiance$139$7,43020 claims
NovartisEntresto$138$5,55816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few adult medicine providers in Oregonon file to place this against a meaningful peer group, so we don't.

Other adult medicine in Gresham

Where these figures come from

Is this you, or does something look wrong? →